EcoDrugPlus

Amiloride-Sensitive Amine Oxidase [Copper-Containing]-Like

Ensembl ID : ENSSTUG00000000577
Gene Symbol: LOC115149506
3 Cross references
225 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSSTUG00000009622
Gene Symbol: APP
3 Cross references
199 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSSTUG00000044041
Gene Symbol: APP
3 Cross references
196 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSSTUG00000006124
Gene Symbol: APP
3 Cross references
197 Possible Orthologues:

Amyloid-Beta A4 Protein-Like

Ensembl ID : ENSSTUG00000010970
Gene Symbol: LOC115156313
3 Cross references
199 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSSTUG00000028332
Gene Symbol: AR
3 Cross references
206 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSSTUG00000036325
Gene Symbol: AR
3 Cross references
207 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSSTUG00000000160
Gene Symbol: LOC115167995
2 Cross references
200 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSSTUG00000006008
Gene Symbol: LOC115205652
2 Cross references
199 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSSTUG00000033667
Gene Symbol: AGTR1
3 Cross references
193 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSSTUG00000020334
Gene Symbol: AGTR1
3 Cross references
193 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSSTUG00000032460
Gene Symbol: AGTR2
3 Cross references
181 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).